(Q34254800)

31 July 2017

title

The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy (English)

1 reference

31 July 2017

0 references

Enrica Riva

1

1 reference

31 July 2017

Filippo Salvini

2

1 reference

31 July 2017

Maria Laura Garlaschi

3

1 reference

31 July 2017

Giovanni Radaelli

4

1 reference

31 July 2017

Marcello Giovannini

5

1 reference

31 July 2017

language of work or name

1 reference

3 May 2012

1 reference

31 July 2017

published in

BMC Infectious Diseases

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

page(s)

106

1 reference

A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Streptococcus pneumoniae serotype 19A in children, South Korea

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Epidemiological differences among pneumococcal serotypes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-106

Declining invasive pneumococcal disease mortality in the United States, 1990-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-106

Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-106

Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-106

Active surveillance of Streptococcus pneumoniae bacteremia in Italian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-106

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-106

Invasive pneumococcal infections in infants up to three years of age: results of a longitudinal surveillance in North-East Italy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3406943

The current status of invasive pneumococcal disease in Poland

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-106

Immune-protective antibodies against capsular polysaccharides do not affect natural competence of Streptococcus pneumoniae: implications for current conjugate vaccination strategies?

21 January 2018

1 reference

12 December 2020

Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention

1 reference

12 December 2020

Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil

1 reference

12 December 2020

Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003

1 reference

12 December 2020

Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine

1 reference

12 December 2020

Pneumococcal conjugate vaccine for childhood immunization--WHO position paper

1 reference

12 December 2020

Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-12-106

1 reference

Dimensions Publication ID

31 July 2017

1014142087

0 references

Fatcat ID

release_4h6yqsa64bhzlos6que66bswhu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4h6yqsa64bhzlos6que66bswhu

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3406943

1 reference

31 July 2017

1 reference